Endocrinology

Advanced Heart Failure and Transplant

Questions discussed in this category

How many days prior to surgery do you recommend stopping SGLT2 inhibitors and when is it safe to resume therapy?

2 Answers available

How should clinicians balance the use of finerenone with other heart failure treatments like SGLT2 inhibitors, considering their glycemic benefits?

Butt et al., PMID 39818225

2 Answers available

Are recurrent UTIs a contraindication to SGLT2i use?

4 Answers available

When do you recommend screening patients with T2DM for heart failure?

2 Answers available

Is there enough evidence now to use injectable semaglutide as a foundational therapy for symptomatic heart failure with preserved ejection fraction in the setting of overweight or obesity?

1 Answer available

Papers discussed in this category

The New England journal of medicine, 2023 Aug 25

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.

European heart journal, 2016-07-14

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.

The New England journal of medicine, 2024 Sep 01

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

Circulation, 2024 Sep 28

Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure.

Related Topics in Endocrinology